News Release

October 30, 2019

ReAlta Life Sciences, Inc. To participate In BIO-Europe® 2019 – 25th Annual International Partnering Conference

Norfolk, VA, October 30, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming BIOEurope® 2019 – 25th Annual International Partnering Conference being held November 11-13, 2019 in Hamburg, Germany. At the conference, the ReAlta team will meet with pharmaceutical companies to discuss its PIC1 technology platform and co-development opportunities, as well as institutional investors and industry partners.

About BIO-Europe®  BIO-Europe is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high-profile exhibition, and private, prescheduled one-on-one meetings. The BIO-Europe 2019 partnering event is expected to draw over 4,000 industry attendees for three days of high-level networking, representing upwards of 2,300 companies from over 50 countries.

ABOUT REALTA — ReAlta Life Sciences, Inc. is an early stage biotech company incorporated in late 2018, and located in Norfolk, Virginia. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.

Companies interested in meeting with ReAlta at BIO-Europe are asked to request a meeting through the event’s partneringONE® online system or to contact Tom Filipczak at


Feb 16, 2021

ReAlta Life Sciences Doses First Subject In Phase 1 Healthy Volunteers Study...

Norfolk, VA, February 16, 2021 – ReAlta Life Sciences, Inc. (“ReAlta”), a company addressing life-threatening diseases through harnessing the power...

Read More
Dec 03, 2020

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 For The...

Norfolk, VA, December 3, 2020 — ReAlta Life Sciences, Inc., today announced that the European Medicines Agency (EMA) has granted Orphan...

Read More
Nov 19, 2020

ReAlta Life Sciences Featured In Norfolk Innovation Corridor, Launch Of New Technology...

Norfolk, VA, November 19, 2020 — Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is...

Read More